GLP - 3 Retatrutide 30mg (out for testing, eta 5/6/2026)

GLP-3 Retatrutide

• Studied for triple-agonist metabolic regulation (GLP-1, GIP, glucagon receptors).

• Research suggests significant effects on weight loss and appetite control.

• Investigated for metabolic disease and cardiovascular risk reduction.